drugset / Trial / NCT02910102
Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia
RandomizedCrossoverQuadruple-blindTreatment
Summary
This study seeks to evaluate the effect of intepirdine (RVT-101) on gait and balance in patients with Alzheimer's Disease, Dementia with Lewy Bodies or Parkinson's Disease Dementia.
Timeline
- Start
- 2016-10
- Primary completion
- 2017-11
- Completion
- 2017-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | intepirdine | Small molecule | 35 mg | Oral |